Adial Pharmaceuticals's total assets for Q2 2025 were $6.80M, an increase of 97.09% from the previous quarter. ADIL total liabilities were $1.21M for the fiscal quarter, a -8.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.